The Patient Experience with Belantamab Mafodotin: Perspectives of Patients Receiving Treatment in Clinical Trials and in the Real-World
Publication
, Conference
Suvannasankha, A; LeBlanc, TW; Correll, JR; Carmichael, C; Gorsh, B; Martin, M; Kitchen, H; Eliason, L; Thursfield, M; Boytsov, N; Lewis, MB ...
Published in: Blood
November 15, 2022
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 15, 2022
Volume
140
Issue
Supplement 1
Start / End Page
13264 / 13266
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Suvannasankha, A., LeBlanc, T. W., Correll, J. R., Carmichael, C., Gorsh, B., Martin, M., … Kleinman, D. (2022). The Patient Experience with Belantamab Mafodotin: Perspectives of Patients Receiving Treatment in Clinical Trials and in the Real-World. In Blood (Vol. 140, pp. 13264–13266). American Society of Hematology. https://doi.org/10.1182/blood-2022-159637
Suvannasankha, Attaya, Thomas W. LeBlanc, Julia R. Correll, Chloe Carmichael, Boris Gorsh, Mona Martin, Helen Kitchen, et al. “The Patient Experience with Belantamab Mafodotin: Perspectives of Patients Receiving Treatment in Clinical Trials and in the Real-World.” In Blood, 140:13264–66. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-159637.
Suvannasankha A, LeBlanc TW, Correll JR, Carmichael C, Gorsh B, Martin M, et al. The Patient Experience with Belantamab Mafodotin: Perspectives of Patients Receiving Treatment in Clinical Trials and in the Real-World. In: Blood. American Society of Hematology; 2022. p. 13264–6.
Suvannasankha, Attaya, et al. “The Patient Experience with Belantamab Mafodotin: Perspectives of Patients Receiving Treatment in Clinical Trials and in the Real-World.” Blood, vol. 140, no. Supplement 1, American Society of Hematology, 2022, pp. 13264–66. Crossref, doi:10.1182/blood-2022-159637.
Suvannasankha A, LeBlanc TW, Correll JR, Carmichael C, Gorsh B, Martin M, Kitchen H, Eliason L, Thursfield M, Boytsov N, Brown Hajdukova E, Lewis MB, Mackay C, Paka P, O’Neill A, Perera S, Naine S, Molinari A, Hanna M, Kleinman D. The Patient Experience with Belantamab Mafodotin: Perspectives of Patients Receiving Treatment in Clinical Trials and in the Real-World. Blood. American Society of Hematology; 2022. p. 13264–13266.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 15, 2022
Volume
140
Issue
Supplement 1
Start / End Page
13264 / 13266
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology